1.
To Assess the Beneficial Effects of Rosuvastatin Before Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome. mfm. 2024;30(10). Accessed December 26, 2025. https://medicalforummonthly.com/index.php/mfm/article/view/4945